Skip to main content
4SC AG logo

4SC AG — Investor Relations & Filings

Ticker · VSC ISIN · DE000A3E5C40 LEI · 391200QOKN7LGVP0RQ86 F Manufacturing
Open in API
Filings indexed 719 across all filing types
Latest filing 2020-01-09 Regulatory Filings
Country DE Germany
Listing F VSC

About 4SC AG

https://www.4sc.com/

4SC AG is a biopharmaceutical company that formerly focused on the research and development of small-molecule drugs for cancer treatment. The company's strategy centered on addressing diseases with high unmet medical needs by developing innovative therapies that targeted epigenetic mechanisms of action. According to the company's official statements, it currently has no products under development and no operational business.

Recent filings

Filing Released Lang Actions
4SC AG: 3 upcoming conferences
Regulatory Filings Classification · 1% confidence The document is a short corporate news release dated January 9, 2020, announcing that 4SC AG will participate in three upcoming financial and scientific conferences (J.P. Morgan Healthcare Conference, Swiss HLG Winter Conference, and World Congress of Cutaneous Lymphomas). It details the dates and locations and mentions management availability for one-on-one meetings. This is not a full financial report (like 10-K or IR), an earnings release (ER), or a presentation (IP). It is a general announcement about corporate activities intended for investors and the public, distributed via DGAP. Since it doesn't fit the specific categories like DIRS, DIV, or CAP, and it is a general corporate update distributed through a regulatory news service, the most appropriate classification is the general regulatory announcement fallback category, RNS, as it is a 'Corporate News' announcement.
2020-01-09 English
4SC AG enters into avelumab supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer for clinical combination study of domatinostat in Merkel cell carcinoma
Regulatory Filings Classification · 1% confidence The document is a press release dated January 7, 2020, announcing that 4SC AG has entered into a supply agreement with Merck KGaA and Pfizer for avelumab to be used in a clinical combination study (MERKLIN 2 study). It contains standard press release formatting, including a headline, date, boilerplate about the issuer being solely responsible, contact information, and dissemination details via DGAP (a service often used for regulatory news). This type of announcement, detailing a specific business development (a supply agreement for clinical trials), does not fit neatly into the defined categories like 10-K, ER, or IR. It is a corporate news item. Since it is a specific announcement that doesn't match the other specialized codes (like M&A (TAR) or Financing (CAP)), the most appropriate general category for significant, non-financial regulatory/corporate news that doesn't fit elsewhere is Regulatory Filings (RNS), which serves as a fallback for miscellaneous corporate announcements distributed via official channels.
2020-01-07 English
Declaration of Voting Results & Voting Rights Announcements 2019
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled 'Voting Rights Announcements' and explicitly states 'Notification of Major Holdings' under German securities law (WpHG). It details changes in the percentage of voting rights held by a specific entity (ATHOS KG and related parties) in 4SC AG, crossing specific thresholds. This directly corresponds to the definition of a Major Shareholding Notification, which tracks changes in significant ownership levels. The relevant filing code is MRQ (Major Shareholding Notification). Although the document mentions 'Voting Rights Announcements' in the header, the content is a detailed disclosure of shareholding changes, which MRQ covers better than DVA (Declaration of Voting Results & Voting Rights Announcements), which is typically for the *results* of a vote, not the underlying ownership structure changes triggering disclosure rules.
2019-12-19 English
Report Publication Announcement 2019
Report Publication Announcement Classification · 1% confidence The document is titled "4SC AG: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements." It explicitly states that it is a preliminary announcement regarding the disclosure dates (April 21, 2020, and October 20, 2020) for future Quarterly/Interim statements. Since the document itself is an announcement about the publication schedule of reports, rather than the report content or the report itself, it fits the definition of a Report Publication Announcement (RPA). The document length is short (2542 chars), supporting the idea that it is an announcement rather than the full financial report.
2019-12-19 English
Report Publication Announcement 2019
Report Publication Announcement Classification · 1% confidence The document is a preliminary announcement from 4SC AG, dated December 19, 2019, stating which financial reports (Annual financial report and Financial report (half-year/Q2)) will be disclosed and on what future dates (March 25, 2020, and August 11, 2020, respectively). It does not contain the actual financial data or the full report itself, but rather announces the publication schedule for future reports. According to Rule #2 (The 'MENU VS MEAL' Rule), a short announcement about the publication of reports points towards a Report Publication Announcement (RPA).
2019-12-19 English
Datum:19.12.2019
Report Publication Announcement Classification · 1% confidence The document is a short notification (under 800 characters) that informs stakeholders about the availability of a quarterly management report (Zwischenmitteilung) for the period 01.01.2020 to 31.03.2020. It provides a link to the company's website where the actual report can be accessed. Following the 'Menu vs Meal' rule, this is an announcement of a report publication rather than the report itself, making it a Report Publication Announcement (RPA).
2019-12-19 German

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.